TLR7 and cancer: Therefore, this study links TLR7 signaling to the functional control of Treg cells and identifies Loxoribin as a new therapeutic strategy in cancer treatment, which may offer new opportunities to improve the outcome of cancer immunotherapy by administration of TLR7 agonist.